In the BioHarmony Drug Report Database
Plecanatide
Trulance (plecanatide) is a protein pharmaceutical. Plecanatide was first approved as Trulance on 2017-01-19. It is used to treat constipation in the USA. It is known to target heat-stable enterotoxin receptor. Trulance immediate release’s patents are valid until 2034-06-05 (FDA).
Trade Name
|
Trulance |
|---|---|
Common Name
|
plecanatide |
ChEMBL ID
|
CHEMBL2103867 |
Indication
|
constipation |
Drug Class
|
Peptides |
Image (chem structure or protein)